Cough News and Research

RSS

Respiratory symptoms more likely to develop when people use both e-cigarettes and tobacco cigarettes

Exclusively using (or "vaping") e-cigarettes can help people quit smoking, but many people using e-cigarettes to quit smoking continue to smoke cigarettes.

22 Apr 2021

Doctors scramble to understand long Covid, but causes and prognosis are elusive

One night in March 2020, Joy Wu felt like her heart was going to explode. She tried to get up and fell down. She didn't recognize friends' names in her list of phone contacts. Remembering how to dial 9-1-1 took "quite a bit of time," she recalled recently.

22 Apr 2021

Researchers aim to better understand clinical features associated with COVID-19 mortality

To better understand the COVID-19 clinical feaures associated with mortality, an interdisciplinary team of researchers has investigated important factors and their influence on a patient’s death.

22 Apr 2021

Censorship or misinformation? Desantis and YouTube spar over Covid roundtable takedown.

In early April, YouTube took down a video featuring Florida Gov. Ron DeSantis and a group of controversial scientists at a March 18 coronavirus roundtable. The online video platform, owned by Google, cited as its rationale that the video contained false statements about the efficacy of children's mask-wearing.

21 Apr 2021

Researchers explain how online symptom checkers generate probable diagnoses and suggestions

Have you recently turned to your mobile device or computer to find out if your cough, sniffle or fever could be caused by COVID-19?

21 Apr 2021

Researchers identify differences in immune response in asymptomatic versus severe COVID-19 cases

The largest study of its type in the UK has identified differences in the immune response to COVID-19, between people with no symptoms, compared to those suffering a more serious reaction to the virus.

21 Apr 2021

Study investigates severe lung injuries among e-cigarette users in rural Appalachia

Just as e-cigarette ingredients can vary from one region to another, the health effects of vaping can have regional characteristics as well. A new study out of West Virginia University suggests that rural e-cigarette users are older--and often get sicker--than their urban counterparts.

20 Apr 2021

Researchers identify risk factors for SARS-CoV-2 reinfection

A team of scientists from the Capital Medical University and Peking University, China, has recently explored the factors responsible for the reactivation of SARS-CoV-2 infection among individuals who have recently recovered from COVID-19. The findings reveal that individuals with lower lymphocyte count or with two or fewer symptoms during the first COVID-19 episode are at higher risk of recurrent infection.

16 Apr 2021

A new approach to estimate the risks of exposure to COVID-19 under different indoor settings

Two MIT professors have proposed a new approach to estimating the risks of exposure to Covid-19 under different indoor settings.

16 Apr 2021

Feline model of SARS-CoV-2 infection imitates COVID-19 in humans

Researchers in the United States have validated a feline model of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that closely imitates coronavirus disease 2019 (COVID-19) in humans.

15 Apr 2021

More than half of COVID-19 patients report persistent symptoms 12-months after infection

In a new study, appearing on the pre-print server medRxiv*, researchers at the University of Trieste and Istituto Auxologico Italiano IRCCS in Italy report that more than half of patients with previous mild-to-moderate symptomatic COVID-19 complained of the persistence of at least one symptom 12-months after the onset of the illness.

15 Apr 2021

Early monoclonal antibody therapies beneficial for COVID-19, finds study

A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB) therapies in preventing disease progression among patients with mild to moderate COVID-19. The findings reveal that the timing of initiating MAB therapy is a crucial factor in determining its efficacy against COVID-19.

14 Apr 2021

Biology of single-celled organisms reveals potential treatment target for COPD

In a series of experiments that began with amoebas -- single-celled organisms that extend podlike appendages to move around -- Johns Hopkins Medicine scientists say they have identified a genetic pathway that could be activated to help sweep out mucus from the lungs of people with chronic obstructive pulmonary disease a widespread lung ailment.

13 Apr 2021

SARS-CoV-2 viable 21 days in blood, mucus, semen, urine, but just 24 hours in breast milk

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), spreads through respiratory droplets and aerosols expelled when infected individuals cough, sneeze, breathe or sing.

13 Apr 2021

The interaction between blood clotting and SARS-CoV-2 infection

Coagulopathy - a condition in which the blood's ability to clot is impaired, is recognized as a significant aspect of morbidity in COVID-19 patients. In a recent study, Prof Lewis Cantley and a team of researchers explored the role of coagulation factors in the SARS-CoV-2 infection. Their recent study is posted on the bioRxiv server.

7 Apr 2021

COVID-19 antibodies persist in breast milk for months following mother’s vaccination

Nursing mothers who receive a COVID-19 vaccine may pass protective antibodies to their babies through breast milk for at least 80 days following vaccination, suggests new research from Washington University School of Medicine in St. Louis.

7 Apr 2021

Analysis finds low adherence to UK's test, trace, and isolate system

Levels of adherence to the UK’s test, trace, and isolate system and understanding of the main symptoms of covid-19 are low, particularly among men, younger age groups, people with a dependent child in the home, key workers, and those experiencing greater financial hardship, finds an analysis of online survey data published by The BMJ today.

1 Apr 2021

Cough News and Research

Respiratory symptoms more likely to develop when people use both e-cigarettes and tobacco cigarettes

Doctors scramble to understand long Covid, but causes and prognosis are elusive

Researchers aim to better understand clinical features associated with COVID-19 mortality

Censorship or misinformation? Desantis and YouTube spar over Covid roundtable takedown.

Researchers explain how online symptom checkers generate probable diagnoses and suggestions

Researchers identify differences in immune response in asymptomatic versus severe COVID-19 cases

Study investigates severe lung injuries among e-cigarette users in rural Appalachia

Researchers identify risk factors for SARS-CoV-2 reinfection

A new approach to estimate the risks of exposure to COVID-19 under different indoor settings

Feline model of SARS-CoV-2 infection imitates COVID-19 in humans

More than half of COVID-19 patients report persistent symptoms 12-months after infection

Early monoclonal antibody therapies beneficial for COVID-19, finds study

Biology of single-celled organisms reveals potential treatment target for COPD

SARS-CoV-2 viable 21 days in blood, mucus, semen, urine, but just 24 hours in breast milk

The interaction between blood clotting and SARS-CoV-2 infection

COVID-19 antibodies persist in breast milk for months following mother’s vaccination

Analysis finds low adherence to UK's test, trace, and isolate system

Oxford-AstraZeneca vaccine effective against B.1.1.7 SARS-CoV-2 variant

Male fetuses impair the maternal and placental immune response to SARS-CoV-2 infection in pregnancy, finds study

mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News